Immunohistochemical markers of prolonged survival in small cell carcinoma of the lung: An immunohistochemical study

Archives of Pathology and Laboratory Medicine

Volumn 120, Issue 5, 1996, Pages 465-472

  Sloman, Andrew ^a   D'Amico, Frank ^b   Yousem, Samuel A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b DUQUESNE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CATHEPSIN B; CATHEPSIN D; CISPLATIN; COLLAGENASE; CORTICOTROPIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; HERMES ANTIGEN; ONCOPROTEIN; PROTEIN P53; VINCRISTINE;

ANTIGEN FUNCTION; ARTICLE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; RETROSPECTIVE STUDY; SMALL CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0029902993     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wittes R. Small cell lung cancer: an overview of issues in therapy. Semin Surg Oncol. 1993;9:127-134.
2. Kayser K, Fitzer M, Bülzebruck H, Bosslet K, Drings P. TNM stage, immunohistology, syntactic structure analysis and survival in patients with small cell anaplastic carcinoma of the lung. Cancer Res Clin Oncol. 1987;113:473-480.
3. Allan G, Hay FG, McIntyre MA, Leonard RCF. Prognosis in small cell carcinoma of the lung: relationship to human milk fat globule 2 (HMFG2) antigen and other small cell associated antigens. Br J Cancer. 1987;56:485-488.
4. Segawa Y, Ohnoshi T, Ueoka H, Kimura I. Neural cell adhesion molecule expression and clinical features in small cell lung cancer: a semiquantitative immunohistochemical approach using an immunogold-silver staining method. Acta Med Okayama. 1993;47:281-287.
5. Kasurinen I, Syrjänen KJ. Peptide hormone immunoreactivity and prognosis in small cell carcinoma of the lung. Respiration. 1986;49:61-67.
6. Sheppard MN, Morittu L, Addis B, Souhami RL, Bobrow LC. Analysis of antigenic phenotype in small cell lung carcinoma in patients with long and short term survival. Lung Cancer. 1993;A59.
7. Bobrow LG, Hirsch FR, Hay FG, et al. An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer. Br J Cancer. 1992;66:547-551.
8. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex in immunoperoxidase techniques. J Histochem Cytochem. 1982;29:577-580.
9. Crown JPA, Chahinian AP, Jaffrey IS, Glidewell MA, Kaneko M, Holland JF. Predictors of 5-year survival and curability in small cell lung cancer. Cancer. 1990;66:382-386.
10. Johnson BE, Steinberg SM, Phelps R, Edison M, Veach SR, Ihde DC. Female patients with small cell lung cancer live longer than male patients. Am J Med. 1988;85:194-196.
11. Spiegelman D, Maurer LH, Ware JH, et al. Prognostic factors in small cell carcinoma of the lung: an analysis of 1521 patients. J Clin Oncol. 1989;7:344-354.
12. Wolf M, Holle R, Hans K, Drings P, Havemann K. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLS): the role of sex as a predictor for survival. Br J Cancer. 1991;63:986-992.
13. Bepler G, Neumann K, Holle R, Havemann K, Kalbfleisch H. Clinical relevance of histologic subtyping in small cell lung cancer. Cancer. 1989;64:74-79.
14. Fraire AE, Johnson EH, Yesner R, Zhang XB, Spjut HJ, Greenberg SD. Prognostic significance of histopathologic subtype and stage in small cell lung cancer. Hum Pathol. 1992,23:520-528.
15. Sforza V, Santopietro R, Bindi M, Tucci E, Pirtoli L, Tosi P. Clinical, histological, and morphometrical parameters in small cell carcinoma of the lung: correlation with survival. Appl Pathol. 1986;4:90-97.
16. Sunday ME, Choi N, Spindel ER, Chin WW, Mark EJ. Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas. Hum Pathol. 1991;22:1030-1039.
17. Coussens L, Yang-Feng TL, Liao Y-C, et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science. 1985;230:1132-1139.
18. neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res. 1990;50:5184-5191.
19. Shi D, Gongping H, Cao S, et al. Overexpression of the c-erb B-2/neu-encoded p185 protein in primary lung cancer. Mol Carcinog. 1992;5:213-218.
20. Yu D, Wang SS, Dulski KM, Tsai CM, Nicholson GL, Hung MC. c-erb B-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res. 1994;54:3260-3266.
21. Schneider PM, Hung M-C, Chiocca SM, et al. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Center Res. 1989;49:4968-4971.
22. Sozzi G, Miozzo M, Tagliabue E, et al. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res. 1991;51:400-404.
23. Sculier JP, Feld R, Evans WK, et al. Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer. J Clin Oncol. 1985;3:1349-1354.
24. Ebert W, Knoch H, Werle B, Trefz G, Muley TH, Spiess E. Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res. 1994;14:895-900.
25. Sedo A, Krepala E, Kasafirek E. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma. Cancer Res Clin Oncol. 1991;117:249-253.